{
    "title": "Amgen to buy back $6 bln in shares this qtr, provides long-term profit forecast",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10490479/Amgen-plans-6-bln-share-buyback-quarter-shares-jump-8.html",
    "date": "2022-02-08",
    "keywords": [
        "price",
        "forecast",
        "amgen",
        "revenue",
        "drug",
        "beasley",
        "company",
        "pipeline",
        "companys",
        "product",
        "portfolio",
        "monday",
        "treatment",
        "leo",
        "inc",
        "tuesday",
        "quarter",
        "profit",
        "oncology",
        "biotechnology",
        "growth",
        "end",
        "decade",
        "cholesterol",
        "repatha",
        "psoriasis",
        "medicine",
        "otezla",
        "development",
        "analyst",
        "michael",
        "research",
        "note",
        "gordon",
        "phone",
        "interview",
        "track",
        "record",
        "pressure",
        "way",
        "drag",
        "volume",
        "side",
        "advantage",
        "selloff",
        "biotech",
        "sector",
        "decline",
        "executive",
        "robert",
        "bradway",
        "business",
        "review",
        "meeting",
        "strength",
        "flexibility",
        "range",
        "year",
        "street",
        "refinitiv",
        "yee",
        "risk",
        "market",
        "exclusivity",
        "series",
        "promise",
        "cholesteroltargeting",
        "obesity",
        "heart",
        "fourthquarter",
        "competition",
        "covid19",
        "antibody",
        "reporting",
        "dania",
        "nadeem",
        "bengaluru",
        "deena",
        "ramakrishnan",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}